braunoderm z barvilom 50 g/1 g v 100 g dermalna raztopina
b. braun melsungen ag - izopropilalkohol; povidon, jodirani - dermalna raztopina - izopropilalkohol 500 mg / 1 g povidon, jodirani10 mg / 1 g; povidon, jodirani 10 mg / 1 g - povidon-jod
braunoderm z barvilom 50 g/1 g v 100 g dermalna raztopina
b. braun melsungen ag - izopropilalkohol; povidon, jodirani - dermalna raztopina - izopropilalkohol 500 mg / 1 g povidon, jodirani10 mg / 1 g; povidon, jodirani 10 mg / 1 g - povidon-jod
aclasta
sandoz pharmaceuticals d.d. - zoledronska kislina - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - zdravila za zdravljenje bolezni kosti - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. zdravljenje osteoporoze, povezane z dolgoročno sistemsko glukokortikoidnih terapije v post-menopavzi in pri moških povečano tveganje za zlom. zdravljenje paget je bolezen kosti.
gutal
huvepharma nv uitbreidingstraat 80 2600 anwerpen belgija 8 -
tardyferon 80 mg tablete s podaljšanim sproščanjem
železo; železov(ii) sulfat - tableta s podaljšanim sproščanjem - železo 80 mg / 1 tableta železov(ii) sulfat80 mg / 1 tableta; železov(ii) sulfat 80 mg / 1 tableta - železov(ii) sulfat
verzenios
eli lilly nederland b.v. - abemaciclib - neoplazme dojke - antineoplastična sredstva - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
aptamil pregomin allerggy digestive care prašek 400 g
živilo za posebne zdravstvene namene - prašek za peroralno suspenzijo - živilo za posebne zdravstvene namene 400 g / 1 pločevinka - mlečni nadomestki
betadine 200 mg vaginalne globule
alkaloid - int d.o.o. - jod - vaginalna globula - jod 20 mg / 1 vag. globula - povidon-jod
neocate junior nevtralen okus, pločevinka 400 g
prašek - mlečni nadomestki
neocate junior okus jagoda, pločevinka 400 g
prašek - mlečni nadomestki